Gastrointestinal microbiota in children with autism in Slovakia

Physiology and Behavior

Volumn 138, Issue , 2015, Pages 179-187

  Tomova, Aleksandra ^a   Husarova, Veronika ^a   Lakatosova, Silvia ^a   Bakos, Jan ^a   Vlkova, Barbora ^a   Babinska, Katarina ^a   Ostatnikova, Daniela ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Autism; Fecal microbiota; Probiotic

Indexed keywords

OXYTOCIN; PRASTERONE SULFATE; PROBIOTIC AGENT; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; HORMONES; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

ADOLESCENT; ANDROGEN BLOOD LEVEL; ARTICLE; AUTISM; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTEROIDETES; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DESULFOVIBRIO; DIET SUPPLEMENTATION; DISEASE SEVERITY; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FIRMICUTES; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MALE; OXYTOCIN BLOOD LEVEL; PILOT STUDY; PSYCHOLOGIC ASSESSMENT; REAL TIME POLYMERASE CHAIN REACTION; SLOVAKIA; TESTOSTERONE BLOOD LEVEL; AUTISTIC DISORDER; BLOOD; CHEMISTRY; CHILD, PRESCHOOL; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENTS; FECES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; INTERVIEW, PSYCHOLOGICAL; METABOLISM; MICROBIOLOGY; MICROBIOTA; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SIBLINGS; TREATMENT OUTCOME;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FECES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HORMONES; HUMANS; INTERVIEW, PSYCHOLOGICAL; MICROBIOTA; PILOT PROJECTS; PROBIOTICS; PSYCHIATRIC STATUS RATING SCALES; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SIBLINGS; SLOVAKIA; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84910010351     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.10.033     Document Type: Article

References (62)

1. ADDMNS Prevalence of autism spectrum disorder among children aged 8years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014, 63(Suppl. 2):1-21.
2. Coury D.L., Ashwood P., Fasano A., Fuchs G., Geraghty M., Kaul A., et al. Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics 2012, 130(Suppl. 2):S160-S168.
3. Babinská K., Slobodníková L., Jánošíková D., Lakatošová S., Bakoš J., Ostatníková D. The effects of probiotic administration on gastrointestinal functions in children with autism. Act Nerv Super Rediviva 2012, 54:82.
4. Adams J.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol 2011, 11:22.
5. Buie T., Campbell D.B., Fuchs G.J., Furuta G.T., Levy J., Vandewater J., et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010, 125(Suppl. 1):S1-S18.
6. Forsythe P., Sudo N., Dinan T., Taylor V.H., Bienenstock J. Mood and gut feelings. Brain Behav Immun 2010, 24:9-16.
7. Mulle J.G., Sharp W.G., Cubells J.F. The gut microbiome: a new frontier in autism research. Curr Psychiatry Rep 2013, 15:337.
8. Cryan J.F., O'Mahony S.M. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23:187-192.
9. Diaz Heijtz R., Wang S., Anuar F., Qian Y., Bjorkholm B., Samuelsson A., et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011, 108:3047-3052.
10. Rhee S.H., Pothoulakis C., Mayer E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009, 6:306-314.
11. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011, 12:453-466.
12. Rao A.V., Bested A.C., Beaulne T.M., Katzman M.A., Iorio C., Berardi J.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009, 1:6.
13. Bolte E.R. Autism and Clostridium tetani. Med Hypotheses 1998, 51:133-144.
14. Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., Vaisanen M.L., et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000, 15:429-435.
15. Finegold S.M. Therapy and epidemiology of autism-clostridial spores as key elements. Med Hypotheses 2008, 70:508-511.
16. Parracho H.M., Bingham M.O., Gibson G.R., McCartney A.L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005, 54:987-991.
17. Critchfield J.W., van Hemert S., Ash M., Mulder L., Ashwood P. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011, 2011:161358.
18. Finegold S.M., Dowd S.E., Gontcharova V., Liu C., Henley K.E., Wolcott R.D., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010, 16:444-453.
19. Williams B.L., Hornig M., Buie T., Bauman M.L., Cho Paik M., Wick I., et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One 2011, 6:e24585.
20. Finegold S.M. Desulfovibrio species are potentially important in regressive autism. Med Hypotheses 2011, 77:270-274.
21. Song Y., Liu C., Finegold S.M. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 2004, 70:6459-6465.
22. Finegold S.M., Molitoris D., Song Y., Liu C., Vaisanen M.L., Bolte E., et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002, 35:S6-S16.
23. Wang L., Christophersen C.T., Sorich M.J., Gerber J.P., Angley M.T., Conlon M.A. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol 2011, 77:6718-6721.
24. Williams B.L., Hornig M., Parekh T., Lipkin W.I. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. mBio 2012, 3.
25. Anderson G.M. Twin studies in autism: what might they say about genetic and environmental influences. J Autism Dev Disord 2012, 42:1526-1527.
26. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102.
27. Heberling C.A., Dhurjati P.S., Sasser M. Hypothesis for a systems connectivity model of Autism Spectrum Disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability. Med Hypotheses 2013, 80:264-270.
28. Strous R.D., Golubchik P., Maayan R., Mozes T., Tuati-Werner D., Weizman A., et al. Lowered DHEA-S plasma levels in adult individuals with autistic disorder. Eur Neuropsychopharmacol 2005, 15:305-309.
29. Auyeung B., Lombardo M.V., Baron-Cohen S. Prenatal and postnatal hormone effects on the human brain and cognition. Pflugers Arch 2013, 465:557-571.
30. Geier D.A., Kern J.K., King P.G., Sykes L.K., Geier M.R. An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders. Acta Neurobiol Exp (Wars) 2012, 72:1-17.
31. Schopler E., Reichler R.J., DeVellis R.F., Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 1980, 10:91-103.
32. Ozonoff S., Goodlin-Jones B.L., Solomon M. Evidence-based assessment of autism spectrum disorders in children and adolescents. J Clin Child Adolesc Psychol 2005, 34:523-540.
33. Mayes S.D., Calhoun S.L., Murray M.J., Morrow J.D., Yurich K.K., Mahr F., et al. Comparison of scores on the Checklist for Autism Spectrum Disorder, Childhood Autism Rating Scale, and Gilliam Asperger's Disorder Scale for children with low functioning autism, high functioning autism, Asperger's disorder, ADHD, and typical development. J Autism Dev Disord 2009, 39:1682-1693.
34. Le Couteur A., Rutter M., Lord C., Rios P., Robertson S., Holdgrafer M., et al. Autism diagnostic interview: a standardized investigator-based instrument. J Autism Dev Disord 1989, 19:363-387.
35. Guo X., Xia X., Tang R., Zhou J., Zhao H., Wang K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 2008, 47:367-373.
36. Ongol M.P., Asano K. Main microorganisms involved in the fermentation of Ugandan ghee. Int J Food Microbiol 2009, 133:286-291.
37. Delroisse J.M., Boulvin A.L., Parmentier I., Dauphin R.D., Vandenbol M., Portetelle D. Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol Res 2008, 163:663-670.
38. Rinttilä T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004, 97:1166-1177.
39. Wessa, P. Pearson Correlation (v1.0.6) in Free Statistics Software (v1.1.23-r7), Office for Research Development and Education. p. http://www.wessa.net/rwasp_correlation.wasp.
40. Heyman M., Darmon N., Dupont C., Dugas B., Hirribaren A., Blaton M.A., et al. Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology 1994, 106:1514-1523.
41. Saiki T., Mitsuyama K., Toyonaga A., Ishida H., Tanikawa K. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 1998, 33:616-622.
42. Braegger C.P., Nicholls S., Murch S.H., Stephens S., MacDonald T.T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992, 339:89-91.
43. Alcantara C.S., Yang C.H., Steiner T.S., Barrett L.J., Lima A.A., Chappell C.L., et al. Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am J Trop Med Hyg 2003, 68:325-328.
44. Long K.Z., Rosado J.L., Santos J.I., Haas M., Al Mamun A., DuPont H.L., et al. Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections. Infect Immun 2010, 78:1221-1228.
45. Long K.Z., Santos J.I., Rosado J.L., Estrada-Garcia T., Haas M., Al Mamun A., et al. Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections. Am J Clin Nutr 2011, 93:578-585.
46. Kang D.W., Park J.G., Ilhan Z.E., Wallstrom G., Labaer J., Adams J.B., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 2013, 8:e68322.
47. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4586-4591.
48. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
49. Bested A.C., Logan A.C., Selhub E.M. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials. Gut Pathog 2013, 5:4.
50. Hsiao E.Y., McBride S.W., Hsien S., Sharon G., Hyde E.R., McCue T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155:1451-1463.
51. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011, 105:755-764.
52. Bercik P., Park A.J., Sinclair D., Khoshdel A., Lu J., Huang X., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011, 23:1132-1139.
53. MacFabe D.F., Cain N.E., Boon F., Ossenkopp K.P., Cain D.P. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder. Behav Brain Res 2011, 217:47-54.
54. Thomas R.H., Meeking M.M., Mepham J.R., Tichenoff L., Possmayer F., Liu S., et al. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J Neuroinflammation 2012, 9:153.
55. de Magistris L., Familiari V., Pascotto A., Sapone A., Frolli A., Iardino P., et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 2010, 51:418-424.
56. D'Eufemia P., Celli M., Finocchiaro R., Pacifico L., Viozzi L., Zaccagnini M., et al. Abnormal intestinal permeability in children with autism. Acta Paediatr 1996, 85:1076-1079.
57. Liu Z., Li N., Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr 2005, 94:386-393.
58. Nusrat A., Sitaraman S.V., Neish A. Interaction of bacteria and bacterial toxins with intestinal epithelial cells. Curr Gastroenterol Rep 2001, 3:392-398.
59. Altieri L., Neri C., Sacco R., Curatolo P., Benvenuto A., Muratori F., et al. Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers 2011, 16:252-260.
60. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004, 558:263-275.
61. Stilling R.M., Dinan T.G., Cryan J.F. Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav 2014, 13:69-86.
62. Duszczyk-Budhathoki M., Olczak M., Lehner M., Majewska M.D. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate. Neurochem Res 2012, 37:436-447.